Jeong Han-ul, Chief Director of Seoul Face21 Dental Hospital

Seoul Face21 Dental Hospital has been recognized for its clinical capabilities in double-jaw and facial bone surgery, winning grand prizes at domestic and international award ceremonies in succession.

Following the grand prize in the double-jaw and facial bone category at ‘2024 Medical Korea’, Seoul Face21 Dental Hospital also won the grand prize at ‘2025 Medical Korea’, earning the honor for two consecutive years. It also announced that it received the grand prize in the double-jaw surgery category selected by ‘2025 Forbes(Forbes)’.

The Medical Korea Grand Prize is an award that selects institutions leading the development of Korea's bio and medical industries through professional medical services and a patient-centered care system.

An official at Seoul Face21 Dental Hospital said, “By being recognized for our systematic care system and safety management efforts in the fields of double-jaw surgery and facial contouring surgery, which are considered high-difficulty procedures, we achieved the feat of winning for two consecutive years.” In particular, many people consider these surgeries for issues such as correction of facial asymmetry, midface improvement, a protruding mouth, and malocclusion, but quite a few hesitate due to the challenging surgical process.

Chief Director Jeong Han-ul of Seoul Face21 Dental Hospital stated, “I am very pleased to have achieved the valuable results of winning the Medical Korea grand prize for two consecutive years and being selected for the grand prize by Forbes“며 ”I believe this is the result of trust in the hospital philosophy of care that places patient safety first“고 expressed his thoughts.

Meanwhile, according to Seoul Face21 Dental Hospital, Chief Director Jeong Han-ul, an oral and maxillofacial surgeon, is solely in charge of treatment, and the hospital is equipped with digital devices for precise analysis and a safe anesthesia system prepared for contingencies.